Ann: Notice of Annual General Meeting/Proxy Form , page-105

re: Ann: Notice of Annual General Meeting/Pro... Hello abdm,
Reading your posts is always a great pleasure and your detective work surrounding OBJ is second to none.


From my very personal experience, I tend to weigh towards the simpler version when offered 2 in regards to spec stocks.
Having the choice between a well deducted but complicated story and the simple choice of CRs on the horizon when indicators are telling me that this is coming, I have to choose the latter.

The simultaneous action on both stocks of Jeff surrounding one CR and anticipating the other by preparing the way to be voted on at the AGM leaves me little leeway to view this differently.


I have given OBJ years to perform and waited since 2011 for a notice from the original FMCG.
Now we are told that the in house product will actually precede the partnering developments and that to me is a clear warning sign to betray the very reason why I invested in the first place.
The indicators that the FMCG updates first and we develop our pain patch on the heels of a signed licence deal are not in place any more.

I clearly recall you comparing POH with OBJ in the past, pointing out that Glyn's approach to NOT pursue in house projects and burn copious amounts of money would be the cornerstone of the attraction for investing in OBJ and represent the obvious advantage towards POH.
This advantage has slipped way, additionally weakened by attempting such endeavours from a very low share price after years of decline.


My personal risk ratio approach does not allow me to be exposed any longer in such capacity and I have already offloaded several mil of shares and will continue to do so during the ongoing efforts by sohps to keep the price up.


I will maintain a healthy portfolio percentage by all means but will diversify towards other stocks.